Gossamer Bio (GOSS) FCF Margin (2024 - 2026)

Gossamer Bio has reported FCF Margin for 3 years, with the latest figure at 426.76% in Q2 2026.

• On a quarterly basis, FCF Margin fell 1668.0% year-over-year to 426.76% in Q2 2026; TTM through Jun 2026 was 305.19%, a 7848.0% increase from a year earlier, with the FY2025 full-year figure at 353.5%, down 35048.0% from the prior year.
• FCF Margin was 426.76% for Q2 2026 at Gossamer Bio, down from 228.38% in the prior quarter.
• The five-year high for FCF Margin was 121.4% in Q2 2024, with the low at 426.76% in Q2 2026.
• Average FCF Margin over 3 years is 298.24%, with a median of 350.13% recorded in 2025.
• The sharpest annual moves came in 2025 and 2026: FCF Margin plunged 53147 bps in 2025, then surged 17359 bps in 2026.
• Over 3 years, FCF Margin stood at 378.3% in 2024, then grew by 7 bps to 350.13% in 2025, then slipped by 22 bps to 426.76% in 2026.
• The last three FCF Margin figures came in at 426.76% (Q2 2026), 228.38% (Q1 2026), and 350.13% (Q4 2025), per Business Quant data.